25 XP   0   0   10

TRACON Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse TRACON Pharmaceuticals Inc together

PenkeI guess you are interested in TRACON Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of TRACON Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about TRACON Pharmaceuticals Inc

I send you an email if I find something interesting about TRACON Pharmaceuticals Inc.

Quick analysis of TRACON Pharmaceuticals Inc (30 sec.)










What can you expect buying and holding a share of TRACON Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
$-0.02
Expected worth in 1 year
$0.28
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$0.30
Return On Investment
15.9%

For what price can you sell your share?

Current Price per Share
$1.89
Expected price per share
$1.59 - $2.64
How sure are you?
50%

1. Valuation of TRACON Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)

$1.89

Intrinsic Value Per Share

$-14.29 - $6.34

Total Value Per Share

$-14.31 - $6.32

2. Growth of TRACON Pharmaceuticals Inc (5 min.)




Is TRACON Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$809k-$1.1m-$6.5m-85.5%

How much money is TRACON Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1.4m-$7.3m$5.8m392.9%
Net Profit Margin-13.9%0.0%--

How much money comes from the company's main activities?

3. Financial Health of TRACON Pharmaceuticals Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#875 / 1010

Most Revenue
#395 / 1010

Most Profit
#272 / 1010

Most Efficient
#475 / 1010

What can you expect buying and holding a share of TRACON Pharmaceuticals Inc? (5 min.)

Welcome investor! TRACON Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of TRACON Pharmaceuticals Inc.

What can you expect buying and holding a share of TRACON Pharmaceuticals Inc?

First you should know what it really means to hold a share of TRACON Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of TRACON Pharmaceuticals Inc is $1.89. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of TRACON Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in TRACON Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.02. Based on the TTM, the Book Value Change Per Share is $0.08 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.23 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of TRACON Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.010.6%-0.09-4.8%-0.35-18.6%-0.65-34.6%-1.00-52.7%
Usd Book Value Change Per Share0.063.4%0.084.0%-0.23-12.2%-0.36-19.0%0.2814.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.2%0.094.8%
Usd Total Gains Per Share0.063.4%0.084.0%-0.23-12.2%-0.36-18.9%0.3719.5%
Usd Price Per Share0.18-0.63-1.95-2.85-3.62-
Price to Earnings Ratio4.01-0.69--1.39--1.61--1.72-
Price-to-Total Gains Ratio2.76--4.08--34.64--7.23--11.69-
Price to Book Ratio-8.70--3.86-4.04-2.27-1.82-
Price-to-Total Gains Ratio2.76--4.08--34.64--7.23--11.69-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.89
Number of shares529
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.08-0.36
Usd Total Gains Per Share0.08-0.36
Gains per Quarter (529 shares)39.76-188.60
Gains per Year (529 shares)159.04-754.41
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101591496-761-764
2031830813-1522-1518
3047746719-2283-2272
4063662626-3044-3026
5079578532-3804-3780
6095494439-4565-4534
701113110345-5326-5288
801272126252-6087-6042
901431142158-6848-6796
1001590158065-7609-7550

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%2.010.00.016.7%2.018.00.010.0%3.037.00.07.5%3.038.01.07.1%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%5.015.00.025.0%12.027.01.030.0%13.028.01.031.0%
Dividend per Share0.00.04.00.0%2.00.010.016.7%3.00.017.015.0%4.00.036.010.0%4.00.038.09.5%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%5.015.00.025.0%13.026.01.032.5%14.027.01.033.3%

Fundamentals of TRACON Pharmaceuticals Inc

About TRACON Pharmaceuticals Inc

TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel targeted therapeutics for cancer in the United States. Its clinical stage products include envafolimab (KN035), a PD-L1 single-domain antibody for the treatment of refractory soft tissue sarcoma; and YH001, an investigational humanized cytotoxic T-lymphocyte-associated protein 4 IgG1 monoclonal antibody that is in Phase I clinical trial for the treatment of various cancer indications. The company's clinical stage products also include TRC102, a small molecule that is in Phase II clinical trial for the treatment of mesothelioma, and in Phase I clinical trial to treat solid tumors, lung cancer, and glioblastoma; and TJ004309, a CD73 antibody that is in Phase I clinical development for the treatment of solid tumors. In addition, it is developing bispecific antibodies, which are in preclinical stage. It has collaboration and license agreements with 3D Medicines Co., Ltd. and Jiangsu Alphamab Biopharmaceuticals Co., Ltd. for the development of envafolimab; I-Mab Biopharma for the development of CD73 antibody TJ004309 and bispecific antibodies; and cooperative research and development agreement with National Cancer Institute. The company was formerly known as Lexington Pharmaceuticals, Inc. and changed its name to TRACON Pharmaceuticals, Inc. in March 2005. TRACON Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in San Diego, California.

Fundamental data was last updated by Penke on 2024-04-12 19:46:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of TRACON Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit TRACON Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare TRACON Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 14.4% means that $0.14 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of TRACON Pharmaceuticals Inc:

  • The MRQ is 14.4%. The company is making a huge profit. +2
  • The TTM is -13.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ14.4%TTM-13.9%+28.3%
TTM-13.9%YOY--13.9%
TTM-13.9%5Y-20.5%+6.6%
5Y-20.5%10Y-248.0%+227.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.4%-200.1%+214.5%
TTM-13.9%-216.8%+202.9%
YOY--288.3%+288.3%
5Y-20.5%-449.1%+428.6%
10Y-248.0%-605.5%+357.5%
1.1.2. Return on Assets

Shows how efficient TRACON Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare TRACON Pharmaceuticals Inc to the Biotechnology industry mean.
  • 4.3% Return on Assets means that TRACON Pharmaceuticals Inc generated $0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of TRACON Pharmaceuticals Inc:

  • The MRQ is 4.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is -15.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ4.3%TTM-15.9%+20.3%
TTM-15.9%YOY-40.0%+24.1%
TTM-15.9%5Y-24.6%+8.7%
5Y-24.6%10Y-20.8%-3.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.3%-13.3%+17.6%
TTM-15.9%-12.8%-3.1%
YOY-40.0%-11.7%-28.3%
5Y-24.6%-13.9%-10.7%
10Y-20.8%-15.7%-5.1%
1.1.3. Return on Equity

Shows how efficient TRACON Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare TRACON Pharmaceuticals Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means TRACON Pharmaceuticals Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of TRACON Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-146.0%+146.0%
TTM-5Y-75.8%+75.8%
5Y-75.8%10Y-52.5%-23.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.9%+16.9%
TTM--16.1%+16.1%
YOY-146.0%-15.1%-130.9%
5Y-75.8%-19.3%-56.5%
10Y-52.5%-20.2%-32.3%

1.2. Operating Efficiency of TRACON Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient TRACON Pharmaceuticals Inc is operating .

  • Measures how much profit TRACON Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare TRACON Pharmaceuticals Inc to the Biotechnology industry mean.
  • An Operating Margin of 13.4% means the company generated $0.13  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of TRACON Pharmaceuticals Inc:

  • The MRQ is 13.4%. The company is operating less efficient.
  • The TTM is 1.2%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ13.4%TTM1.2%+12.2%
TTM1.2%YOY-+1.2%
TTM1.2%5Y-17.2%+18.4%
5Y-17.2%10Y-235.5%+218.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ13.4%-296.2%+309.6%
TTM1.2%-232.5%+233.7%
YOY--298.2%+298.2%
5Y-17.2%-492.1%+474.9%
10Y-235.5%-632.4%+396.9%
1.2.2. Operating Ratio

Measures how efficient TRACON Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.87 means that the operating costs are $0.87 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of TRACON Pharmaceuticals Inc:

  • The MRQ is 0.866. The company is less efficient in keeping operating costs low.
  • The TTM is 0.488. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.866TTM0.488+0.378
TTM0.488YOY-+0.488
TTM0.4885Y0.319+0.169
5Y0.31910Y5.448-5.129
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8663.231-2.365
TTM0.4883.310-2.822
YOY-3.890-3.890
5Y0.3195.739-5.420
10Y5.4487.876-2.428

1.3. Liquidity of TRACON Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if TRACON Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.89 means the company has $0.89 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of TRACON Pharmaceuticals Inc:

  • The MRQ is 0.893. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.629. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.893TTM0.629+0.264
TTM0.629YOY1.169-0.541
TTM0.6295Y1.663-1.034
5Y1.66310Y2.592-0.930
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8933.890-2.997
TTM0.6294.173-3.544
YOY1.1695.344-4.175
5Y1.6636.126-4.463
10Y2.5926.448-3.856
1.3.2. Quick Ratio

Measures if TRACON Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare TRACON Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.84 means the company can pay off $0.84 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of TRACON Pharmaceuticals Inc:

  • The MRQ is 0.841. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.592. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.841TTM0.592+0.249
TTM0.592YOY1.117-0.525
TTM0.5925Y1.676-1.084
5Y1.67610Y2.783-1.108
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8413.514-2.673
TTM0.5923.998-3.406
YOY1.1175.380-4.263
5Y1.6766.105-4.429
10Y2.7836.404-3.621

1.4. Solvency of TRACON Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of TRACON Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare TRACON Pharmaceuticals Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.08 means that TRACON Pharmaceuticals Inc assets are financed with 108.0% credit (debt) and the remaining percentage (100% - 108.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of TRACON Pharmaceuticals Inc:

  • The MRQ is 1.080. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.757. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.080TTM1.757-0.677
TTM1.757YOY1.048+0.709
TTM1.7575Y0.922+0.836
5Y0.92210Y1.257-0.335
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0800.339+0.741
TTM1.7570.336+1.421
YOY1.0480.271+0.777
5Y0.9220.366+0.556
10Y1.2570.389+0.868
1.4.2. Debt to Equity Ratio

Measures if TRACON Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare TRACON Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of TRACON Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY2.732-2.732
TTM-5Y1.916-1.916
5Y1.91610Y2.260-0.344
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.388-0.388
TTM-0.402-0.402
YOY2.7320.335+2.397
5Y1.9160.426+1.490
10Y2.2600.461+1.799

2. Market Valuation of TRACON Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings TRACON Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare TRACON Pharmaceuticals Inc to the Biotechnology industry mean.
  • A PE ratio of 4.01 means the investor is paying $4.01 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of TRACON Pharmaceuticals Inc:

  • The EOD is 43.263. Based on the earnings, the company is overpriced. -1
  • The MRQ is 4.008. Based on the earnings, the company is cheap. +2
  • The TTM is 0.694. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD43.263MRQ4.008+39.255
MRQ4.008TTM0.694+3.314
TTM0.694YOY-1.392+2.086
TTM0.6945Y-1.607+2.300
5Y-1.60710Y-1.723+0.117
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD43.263-2.264+45.527
MRQ4.008-2.629+6.637
TTM0.694-2.680+3.374
YOY-1.392-4.145+2.753
5Y-1.607-6.257+4.650
10Y-1.723-6.254+4.531
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of TRACON Pharmaceuticals Inc:

  • The EOD is -36.384. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.371. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.471. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-36.384MRQ-3.371-33.013
MRQ-3.371TTM-1.471-1.900
TTM-1.471YOY-1.567+0.097
TTM-1.4715Y-2.352+0.881
5Y-2.35210Y-2.185-0.167
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-36.384-2.973-33.411
MRQ-3.371-3.333-0.038
TTM-1.471-3.553+2.082
YOY-1.567-5.605+4.038
5Y-2.352-8.376+6.024
10Y-2.185-8.865+6.680
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of TRACON Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -8.70 means the investor is paying $-8.70 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of TRACON Pharmaceuticals Inc:

  • The EOD is -93.906. Based on the equity, the company is expensive. -2
  • The MRQ is -8.700. Based on the equity, the company is expensive. -2
  • The TTM is -3.861. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-93.906MRQ-8.700-85.206
MRQ-8.700TTM-3.861-4.839
TTM-3.861YOY4.045-7.905
TTM-3.8615Y2.274-6.134
5Y2.27410Y1.816+0.457
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-93.9061.896-95.802
MRQ-8.7002.115-10.815
TTM-3.8612.093-5.954
YOY4.0452.884+1.161
5Y2.2743.542-1.268
10Y1.8163.916-2.100
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of TRACON Pharmaceuticals Inc.

3.1. Institutions holding TRACON Pharmaceuticals Inc

Institutions are holding 11.875% of the shares of TRACON Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Ikarian Capital, LLC6.07750.0453276553000
2023-12-31Acadian Asset Management LLC0.90960.00034139094139090
2023-12-31Squarepoint Ops LLC0.9060.00014122714122710
2023-12-31Vanguard Group Inc0.57750262772-356968-57.5996
2023-12-31BlackRock Inc0.57410261262-6559-2.449
2023-12-31BOOTHBAY FUND MANAGEMENT, LLC0.56880.001225884400
2023-12-31Geode Capital Management, LLC0.45880208786-4437-2.0809
2023-12-31Millennium Management LLC0.420701914531914530
2023-12-31Renaissance Technologies Corp0.2154098038-36500-27.1299
2023-12-31Johnson & Johnson0.18460.00038400300
2023-12-31State Street Corporation0.165207515400
2023-12-31CI Private Wealth LLC0.126305745500
2023-12-31Northern Trust Corp0.047702169100
2023-12-31Hoylecohen, LLC0.02860.00021300000
2023-12-31Tower Research Capital LLC0.0228010365-42-0.4036
2023-12-31Bank of New York Mellon Corp0.022501025900
2023-12-31Cutler Group LP0.00260120000
2023-12-31Qube Research & Technologies0.001808008000
2023-12-31Truvestments Capital LLC0.0007031800
2023-12-31Royal Bank of Canada0.00060251-13-4.9242
Total 11.31180.04745147361+613914+11.9%

3.2. Funds holding TRACON Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.58270.000126277200
2024-01-31Fidelity Extended Market Index0.18108164000
2024-01-31Fidelity Nasdaq Composite Index0.16260.00017331700
2024-01-31Fidelity Total Market Index0.053502414700
2024-01-31Fidelity Series Total Market Index0.047902159500
2023-12-31Northern Trust Extended Eq Market Idx0.03910.00011761200
2023-12-31NT Ext Equity Mkt Idx Fd - L0.03910.00011761200
2024-01-31Spartan Total Market Index Pool E0.01790808700
2024-02-29State St US Extended Mkt Indx NL Cl C0.01510.0001680000
2023-12-31SSgA U.S. Extended Market Index Class I0.01510680000
2024-02-29State St US Ttl Mkt Indx SL Cl I0.00490220000
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.00470213200
2023-12-31SSgA U.S. Total Market Index Strategy0.004301961-45-2.2433
2023-12-31Northern Trust Wilshire 50000.0040178900
2023-12-31NT US Market Cap Idx Fd - L0.0040178900
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.00380171230.1755
2023-12-31BNYM Mellon SL Market Completion UC10.00320.00011442-23-1.57
2023-09-30BlackRock Extended Mkt Composite0.00260116600
2023-12-31BlackRock Extended Equity Market K0.002301017-2-0.1963
2023-12-31BNYM Mellon NSL Mkt Completion Fund Inst0.00090.000142800
Total 1.18870.0007536018-670.0%

3.3. Insider Transactions

Insiders are holding 2.595% of the shares of TRACON Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-04-26Charles TheuerBUY19913.2

4. Summary

4.1. Key Performance Indicators

The key performance indicators of TRACON Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0640.075-15%-0.231+463%-0.360+666%0.278-77%
Book Value Per Share---0.020-0.271+1245%-0.044+118%0.834-102%2.835-101%
Current Ratio--0.8930.629+42%1.169-24%1.663-46%2.592-66%
Debt To Asset Ratio--1.0801.757-39%1.048+3%0.922+17%1.257-14%
Debt To Equity Ratio----0%2.732-100%1.916-100%2.260-100%
Dividend Per Share----0%-0%0.003-100%0.090-100%
Eps--0.011-0.090+925%-0.351+3314%-0.654+6089%-0.997+9225%
Free Cash Flow Per Share---0.013-0.001-89%-0.317+2339%-0.634+4779%-0.818+6197%
Free Cash Flow To Equity Per Share--0.020-0.108+640%-0.087+536%-0.385+2031%0.013+59%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--6.343--------
Intrinsic Value_10Y_min---14.290--------
Intrinsic Value_1Y_max---0.643--------
Intrinsic Value_1Y_min---2.978--------
Intrinsic Value_3Y_max---0.958--------
Intrinsic Value_3Y_min---7.661--------
Intrinsic Value_5Y_max---0.098--------
Intrinsic Value_5Y_min---10.899--------
Market Cap4300165.800-64%7038294.38616837565.517-58%40295149.980-83%42684605.217-84%41836307.529-83%
Net Profit Margin--0.144-0.139+196%-+100%-0.205+242%-2.480+1820%
Operating Margin--0.1340.012+1057%-+100%-0.172+229%-2.355+1862%
Operating Ratio--0.8660.488+77%-+100%0.319+172%5.448-84%
Pb Ratio-93.906-979%-8.700-3.861-56%4.045-315%2.274-483%1.816-579%
Pe Ratio43.263+91%4.0080.694+478%-1.392+135%-1.607+140%-1.723+143%
Price Per Share1.890+91%0.1750.634-72%1.948-91%2.853-94%3.618-95%
Price To Free Cash Flow Ratio-36.384-979%-3.371-1.471-56%-1.567-53%-2.352-30%-2.185-35%
Price To Total Gains Ratio29.740+91%2.755-4.076+248%-34.642+1357%-7.235+363%-11.688+524%
Quick Ratio--0.8410.592+42%1.117-25%1.676-50%2.783-70%
Return On Assets--0.043-0.159+466%-0.400+1021%-0.246+667%-0.208+578%
Return On Equity----0%-1.4600%-0.7580%-0.5250%
Total Gains Per Share--0.0640.075-15%-0.231+463%-0.357+661%0.368-83%
Usd Book Value---809000.000-7676000.000+849%-1113500.000+38%5224650.000-115%12701950.000-106%
Usd Book Value Change Per Share--0.0640.075-15%-0.231+463%-0.360+666%0.278-77%
Usd Book Value Per Share---0.020-0.271+1245%-0.044+118%0.834-102%2.835-101%
Usd Dividend Per Share----0%-0%0.003-100%0.090-100%
Usd Eps--0.011-0.090+925%-0.351+3314%-0.654+6089%-0.997+9225%
Usd Free Cash Flow---522000.000919000.000-157%-6564000.000+1157%-4294800.000+723%-4367400.000+737%
Usd Free Cash Flow Per Share---0.013-0.001-89%-0.317+2339%-0.634+4779%-0.818+6197%
Usd Free Cash Flow To Equity Per Share--0.020-0.108+640%-0.087+536%-0.385+2031%0.013+59%
Usd Market Cap4300165.800-64%7038294.38616837565.517-58%40295149.980-83%42684605.217-84%41836307.529-83%
Usd Price Per Share1.890+91%0.1750.634-72%1.948-91%2.853-94%3.618-95%
Usd Profit--439000.000-1491750.000+440%-7353000.000+1775%-5174750.000+1279%-5394600.000+1329%
Usd Revenue--3045000.0003011250.000+1%-+100%602250.000+406%1150200.000+165%
Usd Total Gains Per Share--0.0640.075-15%-0.231+463%-0.357+661%0.368-83%
 EOD+4 -4MRQTTM+19 -12YOY+24 -85Y+21 -1310Y+19 -15

4.2. Fundamental Score

Let's check the fundamental score of TRACON Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1543.263
Price to Book Ratio (EOD)Between0-1-93.906
Net Profit Margin (MRQ)Greater than00.144
Operating Margin (MRQ)Greater than00.134
Quick Ratio (MRQ)Greater than10.841
Current Ratio (MRQ)Greater than10.893
Debt to Asset Ratio (MRQ)Less than11.080
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.043
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of TRACON Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.279
Ma 20Greater thanMa 503.934
Ma 50Greater thanMa 1004.958
Ma 100Greater thanMa 2004.319
OpenGreater thanClose1.830
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
EBIT  -5,843-1,470-7,3136,526-787-809-1,5962,003407
EBITDA  -5,832-1,473-7,3056,526-779-809-1,5881,998410
Operating Income  -5,832-1,481-7,3136,534-779-809-1,5881,995407
Net Interest Income  -918-270-1,188-4,319-5,5074,861-64668337



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets10,105
Total Liabilities10,914
Total Stockholder Equity-809
 As reported
Total Liabilities 10,914
Total Stockholder Equity+ -809
Total Assets = 10,105

Assets

Total Assets10,105
Total Current Assets9,090
Long-term Assets1,015
Total Current Assets
Cash And Cash Equivalents 8,564
Other Current Assets 526
Total Current Assets  (as reported)9,090
Total Current Assets  (calculated)9,090
+/-0
Long-term Assets
Property Plant Equipment 942
Long-term Assets  (as reported)1,015
Long-term Assets  (calculated)942
+/- 73

Liabilities & Shareholders' Equity

Total Current Liabilities10,182
Long-term Liabilities732
Total Stockholder Equity-809
Total Current Liabilities
Short-term Debt 236
Accounts payable 9,755
Other Current Liabilities 427
Total Current Liabilities  (as reported)10,182
Total Current Liabilities  (calculated)10,418
+/- 236
Long-term Liabilities
Long-term Liabilities Other 732
Long-term Liabilities  (as reported)732
Long-term Liabilities  (calculated)732
+/- 0
Total Stockholder Equity
Common Stock44
Retained Earnings -240,499
Other Stockholders Equity 239,646
Total Stockholder Equity (as reported)-809
Total Stockholder Equity (calculated)-809
+/-0
Other
Capital Stock44
Cash and Short Term Investments 8,564
Common Stock Shares Outstanding 40,196
Current Deferred Revenue-236
Liabilities and Stockholders Equity 10,105
Net Debt -7,832
Net Invested Capital -809
Net Working Capital -1,092
Property Plant and Equipment Gross 1,148
Short Long Term Debt Total 732



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312012-12-31
> Total Assets 
2,611
2,419
0
0
41,306
38,171
67,101
65,662
60,040
53,522
46,990
37,898
36,614
45,730
37,920
32,890
37,376
36,130
63,861
54,920
48,491
40,648
34,187
27,951
21,212
18,121
15,748
15,650
28,061
37,438
31,654
26,803
32,808
26,557
18,864
15,677
19,666
19,469
8,323
12,190
9,413
10,105
10,1059,41312,1908,32319,46919,66615,67718,86426,55732,80826,80331,65437,43828,06115,65015,74818,12121,21227,95134,18740,64848,49154,92063,86136,13037,37632,89037,92045,73036,61437,89846,99053,52260,04065,66267,10138,17141,306002,4192,611
   > Total Current Assets 
0
2,375
0
0
39,564
35,728
66,970
65,479
59,859
53,306
46,795
37,727
36,508
45,648
37,845
32,812
37,305
36,057
63,795
54,861
48,439
40,603
33,088
26,930
20,270
17,260
14,969
14,956
27,453
36,914
31,217
26,189
31,142
24,936
17,293
14,156
18,020
18,228
7,139
10,991
8,340
9,090
9,0908,34010,9917,13918,22818,02014,15617,29324,93631,14226,18931,21736,91427,45314,95614,96917,26020,27026,93033,08840,60348,43954,86163,79536,05737,30532,81237,84545,64836,50837,72746,79553,30659,85965,47966,97035,72839,564002,3750
       Cash And Cash Equivalents 
2,459
2,276
0
0
39,207
35,000
65,291
61,164
47,152
41,373
43,265
34,020
29,648
35,710
32,221
26,001
32,864
29,467
62,493
34,434
28,193
25,136
22,085
26,336
19,053
16,412
14,134
14,453
26,451
32,131
26,408
25,580
29,901
24,072
16,640
13,580
17,037
17,433
6,610
1,735
7,763
8,564
8,5647,7631,7356,61017,43317,03713,58016,64024,07229,90125,58026,40832,13126,45114,45314,13416,41219,05326,33622,08525,13628,19334,43462,49329,46732,86426,00132,22135,71029,64834,02043,26541,37347,15261,16465,29135,00039,207002,2762,459
       Short-term Investments 
0
0
0
0
0
0
0
0
10,503
10,783
2,225
2,137
5,465
8,703
4,498
5,997
3,000
4,999
4,999
18,933
18,978
13,968
9,984
0
0
0
0
0
0
3,999
4,000
0
0
0
0
0
0
0
0
0
0
0
000000000004,0003,9990000009,98413,96818,97818,9334,9994,9993,0005,9974,4988,7035,4652,1372,22510,78310,50300000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,000
0
0
009,000000000000000000000000000000000000000000
   > Long-term Assets 
0
44
0
0
1,742
2,443
131
183
181
216
195
171
106
82
75
78
71
73
66
59
52
45
1,099
1,021
942
861
779
694
608
524
437
614
1,666
1,621
1,571
1,521
1,646
1,241
1,184
1,199
1,073
1,015
1,0151,0731,1991,1841,2411,6461,5211,5711,6211,6666144375246086947798619421,0211,0994552596673717875821061711952161811831312,4431,74200440
       Property Plant Equipment 
20
20
0
0
53
97
91
143
141
173
152
128
106
82
75
78
71
73
66
59
52
45
38
32
942
23
19
16
13
16
18
40
49
50
49
50
51
51
47
44
40
942
942404447515150495049401816131619239423238455259667371787582106128152173141143919753002020
       Long-term Assets Other 
0
24
0
0
1,689
2,346
40
40
40
43
43
43
0
0
0
0
0
0
0
0
0
0
1,061
989
915
838
760
678
595
508
419
574
1,617
1,571
1,522
1,471
1,420
1,123
1,070
1,016
961
978
9789611,0161,0701,1231,4201,4711,5221,5711,6175744195085956787608389159891,06100000000004343434040402,3461,68900240
> Total Liabilities 
1,205
27,763
0
0
20,919
70,345
17,935
18,871
18,980
22,544
21,670
19,807
18,830
17,394
14,932
15,595
15,560
19,143
21,372
17,962
19,932
19,206
19,382
19,032
17,177
15,423
12,964
12,647
12,575
12,366
11,297
14,888
13,945
14,843
16,074
13,135
22,301
26,620
19,395
27,929
12,497
10,914
10,91412,49727,92919,39526,62022,30113,13516,07414,84313,94514,88811,29712,36612,57512,64712,96415,42317,17719,03219,38219,20619,93217,96221,37219,14315,56015,59514,93217,39418,83019,80721,67022,54418,98018,87117,93570,34520,9190027,7631,205
   > Total Current Liabilities 
667
2,047
0
0
11,918
13,253
12,800
10,886
11,631
14,175
14,198
13,236
13,170
10,243
7,848
9,180
9,824
11,798
15,066
11,332
13,588
13,495
13,554
13,939
12,830
11,834
8,772
9,235
9,953
10,543
10,280
14,888
12,734
13,676
14,953
12,063
11,760
22,371
14,182
27,073
11,702
10,182
10,18211,70227,07314,18222,37111,76012,06314,95313,67612,73414,88810,28010,5439,9539,2358,77211,83412,83013,93913,55413,49513,58811,33215,06611,7989,8249,1807,84810,24313,17013,23614,19814,17511,63110,88612,80013,25311,918002,047667
       Short-term Debt 
0
677
0
0
4,009
4,676
4,749
0
321
1,378
2,417
3,471
3,536
333
343
1,162
1,994
2,837
533
6,258
370
1,084
1,806
2,536
2,570
2,604
1,267
1,746
2,464
3,136
2,739
2,761
2,079
1,391
698
0
0
9,807
0
0
0
236
2360009,807006981,3912,0792,7612,7393,1362,4641,7461,2672,6042,5702,5361,8061,0843706,2585332,8371,9941,1623433333,5363,4712,4171,37832104,7494,6764,009006770
       Short Long Term Debt 
0
0
0
0
0
4,676
0
0
0
1,378
0
0
0
333
343
7,205
1,994
2,837
533
6,258
370
1,084
1,806
2,536
2,570
2,604
1,267
1,746
2,464
2,718
2,739
2,761
2,079
1,391
698
0
0
9,807
0
0
0
0
00009,807006981,3912,0792,7612,7392,7182,4641,7461,2672,6042,5702,5361,8061,0843706,2585332,8371,9947,2053433330001,3780004,67600000
       Accounts payable 
667
1,273
0
0
3,524
3,974
3,524
6,097
6,990
1,163
785
979
1,188
7,801
932
1,096
1,325
1,494
12,480
10,511
12,062
1,464
714
937
1,056
1,355
594
906
1,080
1,725
743
11,182
9,527
4,943
13,439
11,002
10,477
3,923
12,342
16,211
10,622
9,755
9,75510,62216,21112,3423,92310,47711,00213,4394,9439,52711,1827431,7251,0809065941,3551,0569377141,46412,06210,51112,4801,4941,3251,0969327,8011,1889797851,1636,9906,0973,5243,9743,524001,273667
       Other Current Liabilities 
0
1,370
0
0
3,524
246
3,524
6,097
6,990
9,444
9,392
7,579
7,885
850
6,634
7,632
7,830
8,294
2,053
821
1,156
12,411
11,748
11,403
10,260
9,230
7,505
7,489
7,489
1,172
7,541
12,127
10,655
7,195
14,255
1,061
1,283
8,641
1,840
10,862
1,080
427
4271,08010,8621,8408,6411,2831,06114,2557,19510,65512,1277,5411,1727,4897,4897,5059,23010,26011,40311,74812,4111,1568212,0538,2947,8307,6326,6348507,8857,5799,3929,4446,9906,0973,5242463,524001,3700
   > Long-term Liabilities 
0
25,716
0
0
9,001
57,092
5,135
7,985
7,349
8,369
7,472
6,571
5,660
7,151
7,084
6,415
5,736
7,345
6,306
6,630
6,344
5,711
5,828
5,093
4,347
3,589
4,192
3,412
2,622
1,823
1,017
0
1,211
1,167
1,121
1,072
10,541
4,249
5,213
856
795
732
7327958565,2134,24910,5411,0721,1211,1671,21101,0171,8232,6223,4124,1923,5894,3475,0935,8285,7116,3446,6306,3067,3455,7366,4157,0847,1515,6606,5717,4728,3697,3497,9855,13557,0929,0010025,7160
       Long term Debt Total 
0
0
0
0
0
0
3,043
6,812
6,601
7,464
6,586
5,694
4,786
7,130
6,747
6,043
5,329
4,603
6,213
6,258
5,973
5,343
4,704
4,057
3,402
2,739
3,438
2,761
2,079
1,391
698
0
0
0
0
0
0
0
0
0
0
0
000000000006981,3912,0792,7613,4382,7393,4024,0574,7045,3435,9736,2586,2134,6035,3296,0436,7477,1304,7865,6946,5867,4646,6016,8123,043000000
       Long-term Liabilities Other 
0
0
0
0
0
0
522
773
748
905
886
877
874
21
337
372
407
409
93
372
371
368
1,124
1,036
945
850
754
651
543
432
319
0
1,211
1,167
1,121
1,072
1,446
969
914
856
795
732
7327958569149691,4461,0721,1211,1671,21103194325436517548509451,0361,1243683713729340940737233721874877886905748773522000000
       Deferred Long Term Liability 
0
0
0
0
0
2,546
1,570
400
0
0
0
0
0
0
0
0
0
2,333
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000002,3330000000004001,5702,54600000
> Total Stockholder Equity
1,406
-25,344
0
0
20,387
-32,174
49,166
46,791
41,060
30,978
25,320
18,091
17,784
28,336
22,988
17,295
21,816
16,987
42,489
36,958
28,559
21,442
14,805
8,919
4,035
2,698
2,784
3,003
15,486
25,072
20,357
11,915
18,863
11,714
2,790
2,542
-2,635
-7,151
-11,072
-15,739
-3,084
-809
-809-3,084-15,739-11,072-7,151-2,6352,5422,79011,71418,86311,91520,35725,07215,4863,0032,7842,6984,0358,91914,80521,44228,55936,95842,48916,98721,81617,29522,98828,33617,78418,09125,32030,97841,06046,79149,166-32,17420,38700-25,3441,406
   Common Stock
2
2
0
0
8
2
12
12
12
12
12
12
13
16
17
17
17
18
28
30
30
30
30
30
30
4
5
8
14
15
15
16
19
19
20
21
22
23
24
27
31
44
443127242322212019191615151485430303030303028181717171613121212121212280022
   Retained Earnings Total Equity0000000000-193,112-184,173-179,109-174,798-170,806-166,355-162,334-158,398-153,199-146,873-139,660-131,904-122,819-113,065-104,701-98,141-99,311-92,745-85,598-79,284-73,413-65,116-58,590-47,543-41,096-38,175000000
   Accumulated Other Comprehensive Income 0000000000000000-15000-128-12800-107-100-93-86-199-176-152-130-106-82-146-131-121-113-10600-980
   Capital Surplus 
0
0
0
0
0
0
87,329
87,875
88,591
89,556
90,424
91,492
97,055
113,918
115,716
116,589
119,940
121,670
155,526
159,747
160,433
161,072
161,648
162,088
162,403
165,028
169,134
173,801
190,270
204,166
204,515
205,011
0
0
0
0
0
0
0
0
0
0
0000000000205,011204,515204,166190,270173,801169,134165,028162,403162,088161,648161,072160,433159,747155,526121,670119,940116,589115,716113,91897,05591,49290,42489,55688,59187,87587,329000000
   Treasury Stock000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
2,123
0
0
52,116
-47,763
20,349
22,344
28,697
89,638
90,530
91,622
97,207
114,094
115,915
116,675
120,033
121,770
155,633
159,747
160,433
161,200
161,648
162,088
162,403
165,178
169,134
173,801
190,270
204,166
204,515
205,011
218,908
219,471
220,019
226,000
227,257
229,737
245,391
251,674
240,907
239,646
239,646240,907251,674245,391229,737227,257226,000220,019219,471218,908205,011204,515204,166190,270173,801169,134165,178162,403162,088161,648161,200160,433159,747155,633121,770120,033116,675115,915114,09497,20791,62290,53089,63828,69722,34420,349-47,76352,116002,1230



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue12,045
Cost of Revenue-14
Gross Profit12,03112,031
 
Operating Income (+$)
Gross Profit12,031
Operating Expense-18,929
Operating Income-6,898-6,898
 
Operating Expense (+$)
Research Development12,263
Selling General Administrative6,666
Selling And Marketing Expenses0
Operating Expense18,92918,929
 
Net Interest Income (+$)
Interest Income0
Interest Expense-7,304
Other Finance Cost-955
Net Interest Income-8,259
 
Pretax Income (+$)
Operating Income-6,898
Net Interest Income-8,259
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,588-10,208
EBIT - interestExpense = -14,202
-3,588
3,716
Interest Expense7,304
Earnings Before Interest and Taxes (EBIT)-6,8983,716
Earnings Before Interest and Taxes (EBITDA)-6,884
 
After tax Income (+$)
Income Before Tax-3,588
Tax Provision-0
Net Income From Continuing Ops-11,024-3,588
Net Income-3,588
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses18,943
Total Other Income/Expenses Net3,3108,259
 

Technical Analysis of TRACON Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of TRACON Pharmaceuticals Inc. The general trend of TRACON Pharmaceuticals Inc is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine TRACON Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of TRACON Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.51 < 2.62 < 2.64.

The bearish price targets are: 1.59.

Tweet this
TRACON Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of TRACON Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

TRACON Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of TRACON Pharmaceuticals Inc. The current macd is -1.20666246.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the TRACON Pharmaceuticals Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for TRACON Pharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the TRACON Pharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
TRACON Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartTRACON Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of TRACON Pharmaceuticals Inc. The current adx is 21.11.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell TRACON Pharmaceuticals Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
TRACON Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of TRACON Pharmaceuticals Inc. The current sar is 3.25622996.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
TRACON Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of TRACON Pharmaceuticals Inc. The current rsi is 34.28. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
TRACON Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartTRACON Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of TRACON Pharmaceuticals Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the TRACON Pharmaceuticals Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
TRACON Pharmaceuticals Inc Daily Stochastic Oscillator ChartTRACON Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of TRACON Pharmaceuticals Inc. The current cci is -68.27784565.

TRACON Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartTRACON Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of TRACON Pharmaceuticals Inc. The current cmo is -41.13543771.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
TRACON Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartTRACON Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of TRACON Pharmaceuticals Inc. The current willr is -92.12598425.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
TRACON Pharmaceuticals Inc Daily Williams %R ChartTRACON Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of TRACON Pharmaceuticals Inc.

TRACON Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of TRACON Pharmaceuticals Inc. The current atr is 0.87822698.

TRACON Pharmaceuticals Inc Daily Average True Range (ATR) ChartTRACON Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of TRACON Pharmaceuticals Inc. The current obv is 9,521,100.

TRACON Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartTRACON Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of TRACON Pharmaceuticals Inc. The current mfi is 39.59.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
TRACON Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartTRACON Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for TRACON Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

TRACON Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of TRACON Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.279
Ma 20Greater thanMa 503.934
Ma 50Greater thanMa 1004.958
Ma 100Greater thanMa 2004.319
OpenGreater thanClose1.830
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of TRACON Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on TRACON Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about TRACON Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about TRACON Pharmaceuticals Inc

I send you an email if I find something interesting about TRACON Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about TRACON Pharmaceuticals Inc.

Receive notifications about TRACON Pharmaceuticals Inc in your mailbox!